Report cover image

Global Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 197 Pages
SKU # APRC20278138

Description

Summary

According to APO Research, The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Plaque Psoriasis Treatment Medications include Johnson & Johnson, Novartis, Merck, Eli Lilly, Pfizer, UCB, Organon, LEO Pharma and Galectin Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plaque Psoriasis Treatment Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Plaque Psoriasis Treatment Medications, also provides the sales of main regions and countries. Of the upcoming market potential for Plaque Psoriasis Treatment Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plaque Psoriasis Treatment Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Plaque Psoriasis Treatment Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Plaque Psoriasis Treatment Medications sales, projected growth trends, production technology, application and end-user industry.

Plaque Psoriasis Treatment Medications Segment by Company

Johnson & Johnson
Novartis
Merck
Eli Lilly
Pfizer
UCB
Organon
LEO Pharma
Galectin Therapeutics
Dermira
Cellceutix
Biogen
Bayer
AstraZeneca
Amgen
Allergan
AbbVie
Plaque Psoriasis Treatment Medications Segment by Type

Non-biologic Drugs
Biologics
Small Molecule Drugs
Plaque Psoriasis Treatment Medications Segment by Application

Hospital
Clinic
Other
Plaque Psoriasis Treatment Medications Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plaque Psoriasis Treatment Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plaque Psoriasis Treatment Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plaque Psoriasis Treatment Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plaque Psoriasis Treatment Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plaque Psoriasis Treatment Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plaque Psoriasis Treatment Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Plaque Psoriasis Treatment Medications Market Size, 2020 VS 2024 VS 2031
1.3 Global Plaque Psoriasis Treatment Medications Market Size Estimates and Forecasts (2020-2031)
1.4 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts (2020-2031)
1.5 Global Plaque Psoriasis Treatment Medications Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Plaque Psoriasis Treatment Medications Market Dynamics
2.1 Plaque Psoriasis Treatment Medications Industry Trends
2.2 Plaque Psoriasis Treatment Medications Industry Drivers
2.3 Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges
2.4 Plaque Psoriasis Treatment Medications Industry Restraints
3 Plaque Psoriasis Treatment Medications Market by Manufacturers
3.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2020-2025)
3.2 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2020-2025)
3.3 Global Plaque Psoriasis Treatment Medications Average Sales Price by Manufacturers (2020-2025)
3.4 Global Plaque Psoriasis Treatment Medications Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Plaque Psoriasis Treatment Medications Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Plaque Psoriasis Treatment Medications Manufacturers, Product Type & Application
3.7 Global Plaque Psoriasis Treatment Medications Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Plaque Psoriasis Treatment Medications Market CR5 and HHI
3.8.2 Global Top 5 and 10 Plaque Psoriasis Treatment Medications Players Market Share by Revenue in 2024
3.8.3 2024 Plaque Psoriasis Treatment Medications Tier 1, Tier 2, and Tier 3
4 Plaque Psoriasis Treatment Medications Market by Type
4.1 Plaque Psoriasis Treatment Medications Type Introduction
4.1.1 Non-biologic Drugs
4.1.2 Biologics
4.1.3 Small Molecule Drugs
4.2 Global Plaque Psoriasis Treatment Medications Sales by Type
4.2.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Plaque Psoriasis Treatment Medications Sales by Type (2020-2031)
4.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2020-2031)
4.3 Global Plaque Psoriasis Treatment Medications Revenue by Type
4.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2020-2031)
4.3.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2020-2031)
5 Plaque Psoriasis Treatment Medications Market by Application
5.1 Plaque Psoriasis Treatment Medications Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Plaque Psoriasis Treatment Medications Sales by Application
5.2.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Plaque Psoriasis Treatment Medications Sales by Application (2020-2031)
5.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2020-2031)
5.3 Global Plaque Psoriasis Treatment Medications Revenue by Application
5.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2020-2031)
5.3.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2020-2031)
6 Global Plaque Psoriasis Treatment Medications Sales by Region
6.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2020-2031)
6.2.1 Global Plaque Psoriasis Treatment Medications Sales by Region (2020-2025)
6.2.2 Global Plaque Psoriasis Treatment Medications Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Plaque Psoriasis Treatment Medications Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Plaque Psoriasis Treatment Medications Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Plaque Psoriasis Treatment Medications Revenue by Region
7.1 Global Plaque Psoriasis Treatment Medications Revenue by Region
7.1.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Plaque Psoriasis Treatment Medications Revenue by Region (2020-2025)
7.1.3 Global Plaque Psoriasis Treatment Medications Revenue by Region (2026-2031)
7.1.4 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Plaque Psoriasis Treatment Medications Revenue (2020-2031)
7.2.2 North America Plaque Psoriasis Treatment Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Plaque Psoriasis Treatment Medications Revenue (2020-2031)
7.3.2 Europe Plaque Psoriasis Treatment Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Plaque Psoriasis Treatment Medications Revenue (2020-2031)
7.4.2 Asia-Pacific Plaque Psoriasis Treatment Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Comapny Information
8.1.2 Johnson & Johnson Business Overview
8.1.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
8.1.5 Johnson & Johnson Recent Developments
8.2 Novartis
8.2.1 Novartis Comapny Information
8.2.2 Novartis Business Overview
8.2.3 Novartis Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
8.2.5 Novartis Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
8.3.5 Merck Recent Developments
8.4 Eli Lilly
8.4.1 Eli Lilly Comapny Information
8.4.2 Eli Lilly Business Overview
8.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
8.4.5 Eli Lilly Recent Developments
8.5 Pfizer
8.5.1 Pfizer Comapny Information
8.5.2 Pfizer Business Overview
8.5.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
8.5.5 Pfizer Recent Developments
8.6 UCB
8.6.1 UCB Comapny Information
8.6.2 UCB Business Overview
8.6.3 UCB Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
8.6.5 UCB Recent Developments
8.7 Organon
8.7.1 Organon Comapny Information
8.7.2 Organon Business Overview
8.7.3 Organon Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
8.7.5 Organon Recent Developments
8.8 LEO Pharma
8.8.1 LEO Pharma Comapny Information
8.8.2 LEO Pharma Business Overview
8.8.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
8.8.5 LEO Pharma Recent Developments
8.9 Galectin Therapeutics
8.9.1 Galectin Therapeutics Comapny Information
8.9.2 Galectin Therapeutics Business Overview
8.9.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
8.9.5 Galectin Therapeutics Recent Developments
8.10 Dermira
8.10.1 Dermira Comapny Information
8.10.2 Dermira Business Overview
8.10.3 Dermira Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
8.10.5 Dermira Recent Developments
8.11 Cellceutix
8.11.1 Cellceutix Comapny Information
8.11.2 Cellceutix Business Overview
8.11.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
8.11.5 Cellceutix Recent Developments
8.12 Biogen
8.12.1 Biogen Comapny Information
8.12.2 Biogen Business Overview
8.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
8.12.5 Biogen Recent Developments
8.13 Bayer
8.13.1 Bayer Comapny Information
8.13.2 Bayer Business Overview
8.13.3 Bayer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
8.13.5 Bayer Recent Developments
8.14 AstraZeneca
8.14.1 AstraZeneca Comapny Information
8.14.2 AstraZeneca Business Overview
8.14.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
8.14.5 AstraZeneca Recent Developments
8.15 Amgen
8.15.1 Amgen Comapny Information
8.15.2 Amgen Business Overview
8.15.3 Amgen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
8.15.5 Amgen Recent Developments
8.16 Allergan
8.16.1 Allergan Comapny Information
8.16.2 Allergan Business Overview
8.16.3 Allergan Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
8.16.5 Allergan Recent Developments
8.17 AbbVie
8.17.1 AbbVie Comapny Information
8.17.2 AbbVie Business Overview
8.17.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
8.17.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Plaque Psoriasis Treatment Medications Value Chain Analysis
9.1.1 Plaque Psoriasis Treatment Medications Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Plaque Psoriasis Treatment Medications Production Mode & Process
9.2 Plaque Psoriasis Treatment Medications Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Plaque Psoriasis Treatment Medications Distributors
9.2.3 Plaque Psoriasis Treatment Medications Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.